Dr. Bill Young

After receiving degrees in Chemistry from MIT (BS), University of California @ Berkeley (PhD), and Pace University (MBA), Bill was a research chemist for 5 years at IBM before shifting to financial services.

He was a sell-side research analyst covering Major Chemicals for 34 years, with his last 16 years of tenure at DLJ/Credit Suisse. He was a member of the Institutional Investor All-America Research Team from 1976 to 2006, including 17 years with the #1 ranking in his sector. He has been involved in many investment banking transactions, including advisory, M&A, fixed income deals, fairness opinions, and both initial and follow-on equity offerings. Since March, 2007, he has also been Managing Director of ChemSpeak LLC, which performs advisory work for corporations and investors, and since early 2010 has been Senior Advisor to Legacy Ptrs & Co and Cottage Capital, LLC.